Clinical trial
CREST-II: Tiagabine, Sertraline, or Donepezil vs. Unmatched Placebo
NCT00015132 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CREST-II: Tiagabine, Sertraline, or Donepezil vs. Unmatched Placebo
- Lead sponsor
- National Institute on Drug Abuse (NIDA)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 31, 1999
- Completion date
- November 30, 2000
- Enrollment
- 0
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.